101 related articles for article (PubMed ID: 7595548)
21. Differential coupling of mu-, delta-, and kappa-opioid receptors to G alpha16-mediated stimulation of phospholipase C.
Lee JW; Joshi S; Chan JS; Wong YH
J Neurochem; 1998 May; 70(5):2203-11. PubMed ID: 9572309
[TBL] [Abstract][Full Text] [Related]
22. Coupling efficacy and selectivity of the human mu-opioid receptor expressed as receptor-Galpha fusion proteins in Escherichia coli.
Stanasila L; Lim WK; Neubig RR; Pattus F
J Neurochem; 2000 Sep; 75(3):1190-9. PubMed ID: 10936202
[TBL] [Abstract][Full Text] [Related]
23. Up-regulation of spinal mu-opioid receptor function to activate G-protein by chronic naloxone treatment.
Narita M; Mizoguchi H; Nagase H; Suzuki T; Tseng LF
Brain Res; 2001 Sep; 913(2):170-3. PubMed ID: 11549382
[TBL] [Abstract][Full Text] [Related]
24. Alterations in the expression of G-proteins and regulation of adenylate cyclase in human neuroblastoma SH-SY5Y cells chronically exposed to low-efficacy mu-opioids.
Ammer H; Schulz R
Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):263-71. PubMed ID: 8216227
[TBL] [Abstract][Full Text] [Related]
25. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
Capasso A; Sorrentino L; Pinto A
Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
[TBL] [Abstract][Full Text] [Related]
26. Expression of mu-, delta- and kappa-opioid receptors in baculovirus-infected insect cells.
Obermeier H; Wehmeyer A; Schulz R
Eur J Pharmacol; 1996 Dec; 318(1):161-6. PubMed ID: 9007528
[TBL] [Abstract][Full Text] [Related]
27. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
Werling LL; Puttfarcken PS; Cox BM
Mol Pharmacol; 1988 Apr; 33(4):423-31. PubMed ID: 2833686
[TBL] [Abstract][Full Text] [Related]
28. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
[TBL] [Abstract][Full Text] [Related]
29. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.
Piros ET; Prather PL; Loh HH; Law PY; Evans CJ; Hales TG
Mol Pharmacol; 1995 May; 47(5):1041-9. PubMed ID: 7746271
[TBL] [Abstract][Full Text] [Related]
30. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
Liu JG; Prather PL
Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
[TBL] [Abstract][Full Text] [Related]
31. Effects of intracerebroventricular administration of beta-funaltrexamine on DAMGO-stimulated [35S]GTP-gamma-S binding in rat brain sections.
Martin TJ; Sim LJ; Selley DE; deMontis MG; Childers SR
Synapse; 1997 Nov; 27(3):177-82. PubMed ID: 9329153
[TBL] [Abstract][Full Text] [Related]
32. [Molecular pharmacology of opioid receptor mechanisms].
Ueda H
Nihon Yakurigaku Zasshi; 1989 Dec; 94(6):339-49. PubMed ID: 2558062
[TBL] [Abstract][Full Text] [Related]
33. Specific G protein activation and mu-opioid receptor internalization caused by morphine, DAMGO and endomorphin I.
Burford NT; Tolbert LM; Sadee W
Eur J Pharmacol; 1998 Jan; 342(1):123-6. PubMed ID: 9544801
[TBL] [Abstract][Full Text] [Related]
34. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
35. Modulation of G protein-coupled receptors by an estrogen receptor that activates protein kinase A.
Lagrange AH; Ronnekleiv OK; Kelly MJ
Mol Pharmacol; 1997 Apr; 51(4):605-12. PubMed ID: 9106625
[TBL] [Abstract][Full Text] [Related]
36. Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus.
Selley DE; Liu Q; Childers SR
J Pharmacol Exp Ther; 1998 May; 285(2):496-505. PubMed ID: 9580589
[TBL] [Abstract][Full Text] [Related]
37. Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein.
Pak Y; Kouvelas A; Scheideler MA; Rasmussen J; O'Dowd BF; George SR
Mol Pharmacol; 1996 Nov; 50(5):1214-22. PubMed ID: 8913353
[TBL] [Abstract][Full Text] [Related]
38. Expression of the mu-opioid receptor in CHO cells: ability of mu-opioid ligands to promote alpha-azidoanilido[32P]GTP labeling of multiple G protein alpha subunits.
Chakrabarti S; Prather PL; Yu L; Law PY; Loh HH
J Neurochem; 1995 Jun; 64(6):2534-43. PubMed ID: 7760033
[TBL] [Abstract][Full Text] [Related]
39. Sulfhydryl groups on opioid receptors revisited. Evidence for two sulfhydryl groups at or near the active site of the mu opioid receptor.
Ofri D; Simon EJ
Receptor; 1992; 2(2):109-19. PubMed ID: 1335327
[TBL] [Abstract][Full Text] [Related]
40. Opioid agonists binding and responses in SH-SY5Y cells.
Costa EM; Hoffmann BB; Loew GH
Life Sci; 1992; 50(1):73-81. PubMed ID: 1309468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
